Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs

by Abed Agbarya, Ina Sarel, Tomer Ziv-Baran, Sivan Agranat, Orna Schwartz, Ayelet Shai, Sharon Nordheimer, Shlomit Fenig, Yelena Shechtman, Ella Kozlener, Tarek Taha, Haitam Nasrallah, Roma Parikh, Nadav Elkoshi, Carmit Levy, Rasha Khoury, Ronen Brenner
Published 2021-08-01